Certara Inc

Certara reported a second-quarter 2026 net loss of $6.1 million, reversing net income of $1.5 million a year earlier, even as its software segment grew. Software revenue rose 4% to $48.8 million and software bookings climbed 9% to $50.7 million, while services revenue fell 3% to $44.5 million and services bookings dropped 6% to $47.6 million. Total revenue reached $93.3 million, up 1% from $92.4 million, and management reaffirmed full-year revenue guidance of $367 million to $382 million, or growth of 0% to 4%. The quarter included a workforce reduction touching about 5% of the global workforce, expected to generate roughly $13 million in annualized savings, following the May 8 sale of the Regulatory and Medical Writing business and the creation of two business units in May. Certara spent $17.4 million to complete its $100 million share repurchase program in the quarter, and the board approved an additional $50 million for buybacks in the third quarter; Julien Perrier became Chief Commercial Officer effective August 1, 2026. Diluted loss per share was $0.04, adjusted EBITDA fell 3% to $26.2 million, and operating expenses rose to $58.3 million from $50.4 million.

Certara reported a second-quarter net loss of US$55.27 million, a sharp widening from prior periods, alongside an executive reshuffle that includes the departure of President and Chief Commercial Officer Leif Pedersen and the appointments of Julien Perrier as Chief Commercial Officer and Eric Jahn as Chief Information Officer. Revenue edged up slightly to US$93.27 million, and the company reaffirmed its 2026 revenue outlook of US$367 million to US$382 million while expanding its share repurchase authorization to US$150 million. The larger loss and leadership changes raise questions about the company's ability to translate its biosimulation growth opportunity into consistent earnings, though the long-term thesis remains centered on model-informed drug development.

Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. The investigation concerns whether Certara and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On May 11, 2026, Certara reported first quarter 2026 financial results, disclosing a 4% year-over-year decline in services revenue to $57.2 million and a 14% decline in services bookings to $66.6 million, while also announcing an exit from the regulatory business in its service segment. Following this news, Certara’s stock price fell $1.18 per share, or approximately 19%, to close at $5.13 on May 11, 2026. Then, on June 17, 2026, the company announced that Chief Financial Officer John Gallagher had notified Certara of his intent to resign effective July 14, 2026, after which the stock price fell $0.49 per share, or 8.13%, to close at $5.54 on June 18, 2026.

Bragar Eagel & Squire, P.C. is investigating potential claims against Certara, Inc. on behalf of Certara stockholders. The investigation concerns whether Certara violated federal securities laws or engaged in other unlawful business practices. The inquiry follows Certara's May 11, 2026 announcement of first-quarter 2026 financial results, which included a 4% year-over-year decline in services revenue to $57.2 million and a 14% drop in services bookings to $66.6 million. The company also disclosed its exit from the regulatory business within its services segment and described services performance as mixed. Certara shares fell $1.18, or approximately 19%, from $6.31 on May 8, 2026 to close at $5.13 on May 11, 2026.

Johnson Fistel, PLLP is investigating potential claims on behalf of Certara, Inc. investors. The investigation focuses on whether Certara's executive officers violated federal securities laws, following a sharp stock price decline after the company reported first quarter 2026 financial results on May 11, 2026. Certara disclosed a 4% year-over-year decline in services revenue to $57.2 million and a 14% drop in services bookings to $66.6 million, citing softer performance from Tier 1 customers and execution challenges. Then on June 17, 2026, Certara announced the resignation of Chief Financial Officer John Gallagher effective July 14, 2026, with Senior Vice President of Finance and Treasurer Faiz Mohammed named interim CFO. Johnson Fistel is examining whether these events involved non-compliance with federal securities laws, and encourages investors who suffered losses to contact the firm.

Certara announced that Chief Financial Officer John Gallagher will resign on July 14, 2026. The company will appoint Faiz Mohammed as interim CFO until a permanent successor is named. Mohammed currently serves as Certara's Senior Vice President of Finance and Treasurer and brings more than 25 years of experience as a senior finance and accounting executive. Certara shares closed Wednesday at $6.03, down 0.33%, and fell further in overnight trading to $5.88, down 2.49%.